Last 24 quarters of trend data · Healthcare · Eye & Dental Care
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -3.55 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 1.54 | 2.08 | 1.48 | 2.06 | 3.29 | 3.03 | 3.94 | 6.75 | 8.63 | 10.83 | 16.58 | 16.10 | 12.68 | 8.11 | 11.94 | 7.54 | 5.51 | 6.58 | 8.54 | 9.49 | 9.13 |
| — | -31.5% | -62.4% | -69.5% | -61.9% | -72.0% | -76.3% | -58.1% | -32.0% | +33.5% | +38.9% | +113.4% | +130.2% | +23.2% | +39.8% | -20.5% | -39.6% | -35.8% | — | — | — | |
| P/B Ratio | 0.68 | 0.80 | 0.76 | 0.95 | 1.56 | 1.33 | 1.91 | 3.66 | 4.93 | 7.09 | 8.41 | 11.59 | 9.04 | 6.16 | 6.32 | 3.64 | 3.94 | 3.46 | 3.53 | 2.76 | 2.23 |
| — | -39.9% | -60.1% | -74.0% | -68.5% | -81.2% | -77.3% | -68.4% | -45.4% | +15.2% | +33.0% | +218.6% | +129.2% | +78.0% | +79.2% | +32.0% | +77.2% | +120.0% | — | — | — | |
| P/FCF | 10.08 | 1.16 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 76.6% | 73.6% | 76.7% | 76.1% | 77.5% | 79.9% | 74.9% | 74.8% | 71.6% | 55.5% | 69.5% | 70.1% | 61.8% | 44.8% | 57.7% | 59.3% | 46.1% | 42.5% | 42.1% | 42.1% | 34.0% |
| — | -7.8% | +2.4% | +1.7% | +8.2% | +43.8% | +7.7% | +6.7% | +15.9% | +24.0% | +20.4% | +18.3% | +33.9% | +5.5% | +37.0% | +40.9% | +35.5% | +83.2% | +354.2% | +31.0% | +21.2% | |
| Operating Margin | -35.8% | -75.3% | -40.8% | -57.7% | -34.8% | -40.1% | -41.6% | -28.2% | -21.5% | -20.3% | -23.9% | -36.2% | -38.0% | -40.8% | -65.5% | -74.9% | -93.2% | -126.5% | -139.0% | -185.4% | -174.0% |
| — | -87.6% | +2.0% | -104.9% | -62.0% | -97.6% | -74.3% | +22.1% | +43.5% | +50.2% | +63.5% | +51.7% | +59.2% | +67.7% | +52.9% | +59.6% | +46.5% | +44.2% | +50.9% | +42.0% | -3.0% | |
| Net Margin | -29.0% | -66.0% | -35.9% | -51.4% | -28.1% | -32.4% | -35.0% | -21.6% | -14.8% | -14.0% | -17.4% | -30.8% | -32.1% | -40.5% | -66.3% | -75.5% | -97.0% | -133.3% | -147.3% | -196.8% | -186.7% |
| — | -104.0% | -2.3% | -137.9% | -90.1% | -131.8% | -101.1% | +29.9% | +54.0% | +65.5% | +73.7% | +59.2% | +66.9% | +69.6% | +55.0% | +61.6% | +48.0% | +39.1% | +46.5% | -0.7% | -134.9% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -14.0% | -6.3% | -4.6% | -5.9% | -3.3% | -3.5% | -4.2% | -2.9% | -2.1% | -2.3% | -2.8% | -5.6% | -5.7% | -7.8% | -9.1% | -11.2% | -16.8% | -16.3% | -14.4% | -13.5% | -10.9% |
| — | -76.7% | -7.8% | -100.2% | -56.0% | -54.5% | -52.8% | +47.9% | +62.7% | +70.6% | +69.7% | +50.1% | +66.0% | +52.3% | +36.3% | +16.4% | -54.3% | -94.5% | — | — | — | |
| ROA | -12.4% | -4.7% | -3.7% | -5.2% | -3.0% | -3.2% | -3.8% | -2.6% | -1.9% | -2.1% | -2.5% | -5.0% | -5.0% | -6.6% | -6.9% | -7.5% | -10.2% | -10.4% | -9.7% | -9.5% | -7.9% |
| — | -47.3% | +2.8% | -98.9% | -56.3% | -54.5% | -52.3% | +47.9% | +62.5% | +68.7% | +64.2% | +33.6% | +50.7% | +36.9% | +28.7% | +21.3% | -28.6% | -22.9% | +31.0% | -37.7% | -130.4% | |
| ROIC | -13.3% | -6.1% | -4.0% | -5.1% | -3.2% | -3.6% | -4.1% | -3.0% | -2.4% | -2.6% | -3.2% | -5.6% | -5.3% | -5.7% | -5.8% | -6.5% | -8.8% | -9.1% | -8.6% | -8.2% | -7.7% |
| — | -68.0% | +3.2% | -71.1% | -37.4% | -39.0% | -29.8% | +46.8% | +55.3% | +54.9% | +45.9% | +14.5% | +40.1% | +36.7% | +32.2% | +20.7% | -14.7% | -17.8% | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.15 | 0.31 | 0.50 | 0.47 | 0.41 | 0.36 | 0.33 |
| — | -3.4% | -4.7% | -6.1% | -8.4% | +2.8% | +1.6% | +180.2% | +132.8% | +97.7% | -72.2% | -95.0% | -96.2% | -95.6% | -64.1% | -15.6% | +54.0% | +57.9% | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 10.95 | 4.20 | 4.07 | 10.20 | 10.95 | 12.74 | 13.93 | 12.68 | 11.36 | 12.67 | 14.33 | 9.20 | 8.06 | 8.87 | 10.89 | 12.62 | 7.81 | 8.50 | 11.54 | 15.12 | 15.92 |
| — | -67.0% | -70.8% | -19.6% | -3.6% | +0.5% | -2.8% | +37.9% | +40.9% | +42.9% | +31.6% | -27.1% | +3.2% | +4.3% | -5.6% | -16.6% | -51.0% | -58.1% | +69.5% | +33.2% | +126.5% | |
| Quick Ratio | 9.75 | 3.67 | 3.61 | 8.93 | 9.75 | 11.44 | 12.70 | 11.65 | 10.50 | 11.71 | 13.34 | 8.18 | 7.22 | 7.87 | 9.81 | 11.40 | 6.95 | 7.57 | 10.64 | 14.32 | 15.19 |
| — | -67.9% | -71.6% | -23.4% | -7.2% | -2.3% | -4.8% | +42.4% | +45.4% | +48.8% | +36.0% | -28.3% | +4.0% | +4.0% | -7.8% | -20.4% | -54.3% | -60.8% | +76.3% | +44.2% | +140.7% | |
| Interest Coverage | -970.90 | -5397.67 | -4002.00 | -5291.67 | -1828.20 | -2450.50 | -2349.80 | -1361.00 | -1184.20 | -1264.00 | -1009.50 | -1514.17 | -2297.75 | -52.93 | -7.79 | -7.77 | -9.75 | -11.95 | -13.73 | -15.60 | -13.58 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 24 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying RXST stock.
RxSight, Inc.'s current P/E is -3.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
RxSight, Inc.'s current operating margin is -35.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking RxSight, Inc.'s business trajectory between earnings reports.